Is Valsartan registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 28 valid registrations of Valsartan, including ANGINET 160 MG FILM COATED TABLETS (160 mg, Film-coated tablet, SAR 24.50); ANGINET 80 MG FILM COATED TABLETS (80 mg, Film-coated tablet, SAR 22.40); ARBAVAL 160 mg film-coated tablet (160 mg, Film-coated tablet, SAR 27.25); ARBAVAL 320 mg film-coated tablet (320 mg, Film-coated tablet, SAR 35.25); ARBAVAL 40 mg film-coated tablet (40 mg, Film-coated tablet, SAR 12.45).

Is Valsartan approved by the US FDA?

Drugs@FDA lists 27 application product lines for Valsartan, including DIOVAN (Prescription); VALSARTAN (Prescription); VALSARTAN (Prescription); VALSARTAN (Prescription); VALSARTAN (Prescription).

Are there safety signals or safety updates for Valsartan?

US FDA: 8 entries (latest 2026-09-22).

Active substance

Valsartan

SFDA 34
US FDA 27
Health Canada 31
US price lines 8
NHS prices 8
Safety 8

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
ANGINET 160 MG FILM COATED TABLETS	160 mg	Film-coated tablet · Oral use	30 Blister	SAR 24.50	Generic · Prescription	MS Pharma Saudi (MSPS)	Valid
ANGINET 80 MG FILM COATED TABLETS	80 mg	Film-coated tablet · Oral use	30 Blister	SAR 22.40	Generic · Prescription	MS Pharma Saudi (MSPS)	Valid
ARBAVAL 160 mg film-coated tablet	160 mg	Film-coated tablet · Oral use	28 Blister	SAR 27.25	Generic · Prescription	SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO	Valid
ARBAVAL 320 mg film-coated tablet	320 mg	Film-coated tablet · Oral use	28 Blister	SAR 35.25	Generic · Prescription	SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO	Valid
ARBAVAL 40 mg film-coated tablet	40 mg	Film-coated tablet · Oral use	28 Blister	SAR 12.45	Generic · Prescription	SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO	Valid
ARBAVAL 80 mg film-coated tablet	80 mg	Film-coated tablet · Oral use	28 Blister	SAR 24.90	Generic · Prescription	SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO	Valid
ARBITEN 160MG FILM COATED TABLETS	160 mg	Film-coated tablet · Oral use	30 Blister	SAR 32.50	Generic · Prescription	Jordan Sweden Medical and Sterilization Co.	Valid
ARBITEN 80MG FILM COATED TABLETS	80 mg	Film-coated tablet · Oral use	30 Blister	SAR 29.65	Generic · Prescription	Jordan Sweden Medical and Sterilization Co.	Valid
Avysk	160 mg	Film-coated tablet · Oral use	30 Blister	SAR 24.50	Generic · Prescription	Med City Pharma	Valid
Avysk	80 mg	Film-coated tablet · Oral use	30 Blister	SAR 22.40	Generic · Prescription	Med City Pharma	Valid
CINFAVAL 160 mg Film-coated Tablet	160 mg	Film-coated tablet · Oral use	28 Bottle	SAR 22.85	Generic · Prescription	LABORATORIOS CINFA SA	Valid
CINFAVAL 320 mg Film-coated Tablet	320 mg	Film-coated tablet · Oral use	28 Bottle	SAR 29.60	Generic · Prescription	LABORATORIOS CINFA SA	Valid
CINFAVAL 80 mg Film-coated Tablet	80 mg	Film-coated tablet · Oral use	28 Bottle	SAR 20.90	Generic · Prescription	LABORATORIOS CINFA SA	Valid
DIOSTAR 160 mg film-coated tablet	160 mg	Film-coated tablet · Oral use	30 Blister	SAR 24.50	Generic · Prescription	Pharma International Co.	Valid
DIOSTAR 80 mg film-coated tablet	80 mg	Film-coated tablet · Oral use	30 Blister	SAR 22.40	Generic · Prescription	Pharma International Co.	Valid
DIOVAN 160MGTAB	160 mg	Film-coated tablet · Oral use	28 Blister	SAR 42.50	NCE · Prescription	NOVARTIS	Valid
DIOVAN 320MG F.C. TABLETS	320 mg	Film-coated tablet · Oral use	28 Blister	SAR 54.85	NCE · Prescription	NOVARTIS	Valid
DIOVAN 40MG F.C. TABLETS	40 mg	Film-coated tablet · Oral use	28 Blister	SAR 23.05	NCE · Prescription	NOVARTIS	Valid
DIOVAN 80MG TAB	80 mg	Film-coated tablet · Oral use	28 Blister	SAR 38.75	NCE · Prescription	NOVARTIS	Valid
TABUVAN 160 MG FILM COATED TABLET	160 mg	Film-coated tablet · Oral use	30 Blister	SAR 36.10	Generic · Prescription	Tabuk Pharmaceutical Manufacturing Company	Valid
TABUVAN 320 MG FILM COATED TABLET	320 mg	Film-coated tablet · Oral use	30 Blister	SAR 46.60	Generic · Prescription	Tabuk Pharmaceutical Manufacturing Company	Valid
TABUVAN 40 MG FILM COATED TABLET	40 mg	Film-coated tablet · Oral use	30 Blister	SAR 19.60	Generic · Prescription	Tabuk Pharmaceutical Manufacturing Company	Valid
TABUVAN 80 MG FILM COATED TABLET	80 mg	Film-coated tablet · Oral use	30 Blister	SAR 32.95	Generic · Prescription	Tabuk Pharmaceutical Manufacturing Company	Valid
VALISTA 160 mg film-coated tablet	160 mg	Film-coated tablet · Oral use	28 Blister	SAR 30.30	Generic · Prescription	SPIMACO ADDWAEIH	Valid
VALISTA 320 mg film-coated tablet	320 mg	Film-coated tablet · Oral use	28 Blister	SAR 39.15	Generic · Prescription	SPIMACO ADDWAEIH	Valid

9 more — full table

Indications — CHI Daman Drug Formulary

CARDIOMYOPATHY; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; HYPERTENSION; NON-ST WAVE ELEVATED MYOCARDIAL INFARCTION (NSTEMI); SICKLE CELL DISEASE - ALBUMINURIA MANAGEMENT; ST-WAVE ELEVATED MYOCARDIAL INFARCTION (STEMI); SYSTEMIC LUPUS ERYTHEMATOSUS

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
DIOVAN	80MG; 160MG; 320MG; 40MG	tablet · oral	NOVARTIS	Prescription	18 Jul 2001
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	OHM LABS INC	Prescription	26 Jun 2014
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	MYLAN	Prescription	5 Jan 2015
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	ALEMBIC	Prescription	5 Jan 2015
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	AUROBINDO PHARMA LTD	Prescription	5 Jan 2015
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	HETERO LABS LTD V	Prescription	5 Jan 2015
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	JUBILANT GENERICS	Prescription	5 Jan 2015
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	PRINSTON INC	Prescription	9 Jun 2015
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	AMNEAL PHARMS	Prescription	11 Jan 2016
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	MACLEODS PHARMS LTD	Prescription	16 Sep 2016
PREXXARTAN	4MG/ML	solution · oral	CARMEL BIOSCIENCES	Prescription	19 Dec 2017
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	ADAPTIS	Prescription	9 Apr 2018
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	ALKEM LABS LTD	Prescription	12 Mar 2019
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	DR REDDYS	Prescription	5 Oct 2021
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	SCIEGEN PHARMS	Prescription	27 Oct 2021
VALSARTAN	4MG/ML	solution · oral	NOVITIUM PHARMA	Prescription	2 Nov 2021
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	ZYDUS LIFESCIENCES	Prescription	22 Jul 2024
VALSARTAN	4MG/ML	solution · oral	RUBICON RESEARCH	Prescription	5 Jun 2025
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	PHARMOBEDIENT	Prescription	21 Apr 2026
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	BOSTAL DRUG	Prescription	11 Aug 2026
DIOVAN	80MG; 160MG	capsule · oral	NOVARTIS	Discontinued	23 Dec 1996
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	WATSON LABS INC	Discontinued	5 Jan 2015
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	LUPIN	Discontinued	5 Jan 2015
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	TORRENT	Discontinued	5 Jan 2015
VALSARTAN	40MG; 80MG; 160MG; 320MG	tablet · oral	IVAX PHARMS	Discontinued	4 Jan 2016

2 more — full table

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
AURO-VALSARTAN	02414201	40 MG	TABLET · ORAL	AURO PHARMA INC
AURO-VALSARTAN	02414228	80 MG	TABLET · ORAL	AURO PHARMA INC
AURO-VALSARTAN	02414236	160 MG	TABLET · ORAL	AURO PHARMA INC
AURO-VALSARTAN	02414244	320 MG	TABLET · ORAL	AURO PHARMA INC
DIOVAN	02270528	40 MG	TABLET · ORAL	NOVARTIS PHARMACEUTICALS CANADA INC
DIOVAN	02289504	320 MG	TABLET · ORAL	NOVARTIS PHARMACEUTICALS CANADA INC
DIOVAN 160MG TABLETS	02244782	160 MG	TABLET · ORAL	NOVARTIS PHARMACEUTICALS CANADA INC
DIOVAN 80MG TABLETS	02244781	80 MG	TABLET · ORAL	NOVARTIS PHARMACEUTICALS CANADA INC
SANDOZ VALSARTAN	02356740	40 MG	TABLET · ORAL	SANDOZ CANADA INCORPORATED
SANDOZ VALSARTAN	02356759	80 MG	TABLET · ORAL	SANDOZ CANADA INCORPORATED
SANDOZ VALSARTAN	02356767	160 MG	TABLET · ORAL	SANDOZ CANADA INCORPORATED
SANDOZ VALSARTAN	02356775	320 MG	TABLET · ORAL	SANDOZ CANADA INCORPORATED
TARO-VALSARTAN	02363062	40 MG	TABLET · ORAL	SUN PHARMA CANADA INC
TARO-VALSARTAN	02363100	80 MG	TABLET · ORAL	SUN PHARMA CANADA INC
TARO-VALSARTAN	02363119	160 MG	TABLET · ORAL	SUN PHARMA CANADA INC
TEVA-VALSARTAN	02356643	40 MG	TABLET · ORAL	TEVA CANADA LIMITED
TEVA-VALSARTAN	02356651	80 MG	TABLET · ORAL	TEVA CANADA LIMITED
TEVA-VALSARTAN	02356678	160 MG	TABLET · ORAL	TEVA CANADA LIMITED
TEVA-VALSARTAN	02356686	320 MG	TABLET · ORAL	TEVA CANADA LIMITED
VALSARTAN	02366940	40 MG	TABLET · ORAL	SANIS HEALTH INC
VALSARTAN	02366959	80 MG	TABLET · ORAL	SANIS HEALTH INC
VALSARTAN	02366967	160 MG	TABLET · ORAL	SANIS HEALTH INC
VALSARTAN	02366975	320 MG	TABLET · ORAL	SANIS HEALTH INC
VALSARTAN	02367726	40 MG	TABLET · ORAL	PRO DOC LIMITEE
VALSARTAN	02367734	80 MG	TABLET · ORAL	PRO DOC LIMITEE

6 more — full table

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
US NADAC	DIOVAN 160 MG TABLET	$10.03773	per EA	23 Sep 2026
US NADAC	DIOVAN 320 MG TABLET	$12.67445	per EA	23 Sep 2026
US NADAC	DIOVAN 40 MG TABLET	$7.81625	per EA	23 Sep 2026
US NADAC	DIOVAN 80 MG TABLET	$9.32714	per EA	23 Sep 2026
US NADAC	VALSARTAN 160 MG TABLET	$0.10604	per EA	23 Sep 2026
US NADAC	VALSARTAN 320 MG TABLET	$0.16341	per EA	23 Sep 2026
US NADAC	VALSARTAN 40 MG TABLET	$0.0963	per EA	23 Sep 2026
US NADAC	VALSARTAN 80 MG TABLET	$0.08197	per EA	23 Sep 2026
NHS Drug Tariff	Valsartan 160mg capsules	£5.72	28 capsule	1 Oct 2026
NHS Drug Tariff	Valsartan 160mg tablets	£7.97	28 tablet	1 Oct 2026
NHS Drug Tariff	Valsartan 320mg tablets	£4.37	28 tablet	1 Oct 2026
NHS Drug Tariff	Valsartan 3mg/ml oral solution	£7.20	160 ml	1 Oct 2026
NHS Drug Tariff	Valsartan 40mg capsules	£1.99	28 capsule	1 Oct 2026
NHS Drug Tariff	Valsartan 40mg tablets	£3.19	7 tablet	1 Oct 2026
NHS Drug Tariff	Valsartan 80mg capsules	£4.17	28 capsule	1 Oct 2026
NHS Drug Tariff	Valsartan 80mg tablets	£13.69	28 tablet	1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Safety signals and safety-related labeling changes

US FDA 22 Sep 2026 PREXXARTAN — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
US FDA 12 Apr 2024 ENTRESTO — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
US FDA 16 Jun 2023 BYVALSON — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Patient Counseling Information / Patient Information / Medication Guide
US FDA 19 Apr 2021 DIOVAN — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
US FDA 20 Aug 2020 DIOVAN HCT — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
US FDA 20 Aug 2020 EXFORGE HCT — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
US FDA 12 Jun 2019 EXFORGE — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
US FDA 3 Feb 2017 DIOVAN — safety-related labeling change
Labeling sections changed: Adverse Reactions

All safety entries for valsartan →

Combinations containing Valsartan

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.